materials recombinant human wnt3a Search Results


96
ATCC 2014 n a nih3t3 lacz wnt1 wnt3a wnt4 wnt5a wnt7a wnt7b wnt11 kispert
2014 N A Nih3t3 Lacz Wnt1 Wnt3a Wnt4 Wnt5a Wnt7a Wnt7b Wnt11 Kispert, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/2014 n a nih3t3 lacz wnt1 wnt3a wnt4 wnt5a wnt7a wnt7b wnt11 kispert/product/ATCC
Average 96 stars, based on 1 article reviews
2014 n a nih3t3 lacz wnt1 wnt3a wnt4 wnt5a wnt7a wnt7b wnt11 kispert - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

96
Tocris ldn193189 biogems 1062443 chir 99021 tocris 4423 wnt 3a peprotech
Ldn193189 Biogems 1062443 Chir 99021 Tocris 4423 Wnt 3a Peprotech, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ldn193189 biogems 1062443 chir 99021 tocris 4423 wnt 3a peprotech/product/Tocris
Average 96 stars, based on 1 article reviews
ldn193189 biogems 1062443 chir 99021 tocris 4423 wnt 3a peprotech - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

90
R&D Systems wnt3a, 25 ng/ml
Wnt3a, 25 Ng/Ml, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wnt3a, 25 ng/ml/product/R&D Systems
Average 90 stars, based on 1 article reviews
wnt3a, 25 ng/ml - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

94
MedChemExpress hy p70453b dapt medchemexpress
Hy P70453b Dapt Medchemexpress, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hy p70453b dapt medchemexpress/product/MedChemExpress
Average 94 stars, based on 1 article reviews
hy p70453b dapt medchemexpress - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

97
R&D Systems wnt3a
(A) N2A cells were transfected with pCl β-catenin S33Y or pCl empty vector and harvested for expression analysis 2 days later. Results are presented relative to the pCl control. (B, C) N2A cells were treated with either 50 ng/μl <t>Wnt3a</t> (B) or 0.1 ng/μl BMP4 (C) and harvested for RT-qPCR analysis 3 days later. 0.02% BSA in PBS was used as a negative control. (D) Genome browser graphic showing the ChIP amplified candidate CREs as well as the location of the TCF7L2 motifs and sgRNAs used in the CRISPRi experiment (GRCm38/mm10). (E) ChIP assays were performed in N2A cells using either an antibody against TCF7L2 or an isotype specific control. TCF7L2 occupancy at the indicated CREs was analysed by qPCR. Fold enrichment was calculated as 2 −ΔΔCt (IP/IgG) and is presented as mean value +/− sem. n≥3. One-tailed student’s t-test * p<0.05. (F) TCF7L2 levels were knocked-down in N2A cells by transfection of an endoribonuclease-prepared pool of TCF7L2 esiRNAs. An esiRNA pool targeting the luciferase gene was used as a negative control. Cells were harvested for expression analysis 3 days after transfection. (G) N2A cells were transfected with a plasmid co-expressing dCas9-KRAB and a sgRNA targeting the TCF7L2 motif within the indicated candidate CREs. A non-targeting sgRNA was used as a control. For all RT-qPCR reactions: Tcf7l2, Paupar and Pax6 expression levels were measured using RT-qPCR and results were normalised to Tbp. Results are presented as mean values +/− sem, n≥3. One-tailed student’s t-test * p<0.05, ** p<0.01, *** p<0.001.
Wnt3a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wnt3a/product/R&D Systems
Average 97 stars, based on 1 article reviews
wnt3a - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

97
Bio-Techne corporation recombinant human wnt-3a protein
(A) N2A cells were transfected with pCl β-catenin S33Y or pCl empty vector and harvested for expression analysis 2 days later. Results are presented relative to the pCl control. (B, C) N2A cells were treated with either 50 ng/μl <t>Wnt3a</t> (B) or 0.1 ng/μl BMP4 (C) and harvested for RT-qPCR analysis 3 days later. 0.02% BSA in PBS was used as a negative control. (D) Genome browser graphic showing the ChIP amplified candidate CREs as well as the location of the TCF7L2 motifs and sgRNAs used in the CRISPRi experiment (GRCm38/mm10). (E) ChIP assays were performed in N2A cells using either an antibody against TCF7L2 or an isotype specific control. TCF7L2 occupancy at the indicated CREs was analysed by qPCR. Fold enrichment was calculated as 2 −ΔΔCt (IP/IgG) and is presented as mean value +/− sem. n≥3. One-tailed student’s t-test * p<0.05. (F) TCF7L2 levels were knocked-down in N2A cells by transfection of an endoribonuclease-prepared pool of TCF7L2 esiRNAs. An esiRNA pool targeting the luciferase gene was used as a negative control. Cells were harvested for expression analysis 3 days after transfection. (G) N2A cells were transfected with a plasmid co-expressing dCas9-KRAB and a sgRNA targeting the TCF7L2 motif within the indicated candidate CREs. A non-targeting sgRNA was used as a control. For all RT-qPCR reactions: Tcf7l2, Paupar and Pax6 expression levels were measured using RT-qPCR and results were normalised to Tbp. Results are presented as mean values +/− sem, n≥3. One-tailed student’s t-test * p<0.05, ** p<0.01, *** p<0.001.
Recombinant Human Wnt 3a Protein, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human wnt-3a protein/product/Bio-Techne corporation
Average 97 stars, based on 1 article reviews
recombinant human wnt-3a protein - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

94
Bio-Techne corporation recombinant human wnt-3a protein, cf
(A) N2A cells were transfected with pCl β-catenin S33Y or pCl empty vector and harvested for expression analysis 2 days later. Results are presented relative to the pCl control. (B, C) N2A cells were treated with either 50 ng/μl <t>Wnt3a</t> (B) or 0.1 ng/μl BMP4 (C) and harvested for RT-qPCR analysis 3 days later. 0.02% BSA in PBS was used as a negative control. (D) Genome browser graphic showing the ChIP amplified candidate CREs as well as the location of the TCF7L2 motifs and sgRNAs used in the CRISPRi experiment (GRCm38/mm10). (E) ChIP assays were performed in N2A cells using either an antibody against TCF7L2 or an isotype specific control. TCF7L2 occupancy at the indicated CREs was analysed by qPCR. Fold enrichment was calculated as 2 −ΔΔCt (IP/IgG) and is presented as mean value +/− sem. n≥3. One-tailed student’s t-test * p<0.05. (F) TCF7L2 levels were knocked-down in N2A cells by transfection of an endoribonuclease-prepared pool of TCF7L2 esiRNAs. An esiRNA pool targeting the luciferase gene was used as a negative control. Cells were harvested for expression analysis 3 days after transfection. (G) N2A cells were transfected with a plasmid co-expressing dCas9-KRAB and a sgRNA targeting the TCF7L2 motif within the indicated candidate CREs. A non-targeting sgRNA was used as a control. For all RT-qPCR reactions: Tcf7l2, Paupar and Pax6 expression levels were measured using RT-qPCR and results were normalised to Tbp. Results are presented as mean values +/− sem, n≥3. One-tailed student’s t-test * p<0.05, ** p<0.01, *** p<0.001.
Recombinant Human Wnt 3a Protein, Cf, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human wnt-3a protein, cf/product/Bio-Techne corporation
Average 94 stars, based on 1 article reviews
recombinant human wnt-3a protein, cf - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

94
R&D Systems recombinant untagged high purity human wnt 3a
(A) N2A cells were transfected with pCl β-catenin S33Y or pCl empty vector and harvested for expression analysis 2 days later. Results are presented relative to the pCl control. (B, C) N2A cells were treated with either 50 ng/μl <t>Wnt3a</t> (B) or 0.1 ng/μl BMP4 (C) and harvested for RT-qPCR analysis 3 days later. 0.02% BSA in PBS was used as a negative control. (D) Genome browser graphic showing the ChIP amplified candidate CREs as well as the location of the TCF7L2 motifs and sgRNAs used in the CRISPRi experiment (GRCm38/mm10). (E) ChIP assays were performed in N2A cells using either an antibody against TCF7L2 or an isotype specific control. TCF7L2 occupancy at the indicated CREs was analysed by qPCR. Fold enrichment was calculated as 2 −ΔΔCt (IP/IgG) and is presented as mean value +/− sem. n≥3. One-tailed student’s t-test * p<0.05. (F) TCF7L2 levels were knocked-down in N2A cells by transfection of an endoribonuclease-prepared pool of TCF7L2 esiRNAs. An esiRNA pool targeting the luciferase gene was used as a negative control. Cells were harvested for expression analysis 3 days after transfection. (G) N2A cells were transfected with a plasmid co-expressing dCas9-KRAB and a sgRNA targeting the TCF7L2 motif within the indicated candidate CREs. A non-targeting sgRNA was used as a control. For all RT-qPCR reactions: Tcf7l2, Paupar and Pax6 expression levels were measured using RT-qPCR and results were normalised to Tbp. Results are presented as mean values +/− sem, n≥3. One-tailed student’s t-test * p<0.05, ** p<0.01, *** p<0.001.
Recombinant Untagged High Purity Human Wnt 3a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant untagged high purity human wnt 3a/product/R&D Systems
Average 94 stars, based on 1 article reviews
recombinant untagged high purity human wnt 3a - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

95
R&D Systems recombinant mouse wnt3a
(A) N2A cells were transfected with pCl β-catenin S33Y or pCl empty vector and harvested for expression analysis 2 days later. Results are presented relative to the pCl control. (B, C) N2A cells were treated with either 50 ng/μl <t>Wnt3a</t> (B) or 0.1 ng/μl BMP4 (C) and harvested for RT-qPCR analysis 3 days later. 0.02% BSA in PBS was used as a negative control. (D) Genome browser graphic showing the ChIP amplified candidate CREs as well as the location of the TCF7L2 motifs and sgRNAs used in the CRISPRi experiment (GRCm38/mm10). (E) ChIP assays were performed in N2A cells using either an antibody against TCF7L2 or an isotype specific control. TCF7L2 occupancy at the indicated CREs was analysed by qPCR. Fold enrichment was calculated as 2 −ΔΔCt (IP/IgG) and is presented as mean value +/− sem. n≥3. One-tailed student’s t-test * p<0.05. (F) TCF7L2 levels were knocked-down in N2A cells by transfection of an endoribonuclease-prepared pool of TCF7L2 esiRNAs. An esiRNA pool targeting the luciferase gene was used as a negative control. Cells were harvested for expression analysis 3 days after transfection. (G) N2A cells were transfected with a plasmid co-expressing dCas9-KRAB and a sgRNA targeting the TCF7L2 motif within the indicated candidate CREs. A non-targeting sgRNA was used as a control. For all RT-qPCR reactions: Tcf7l2, Paupar and Pax6 expression levels were measured using RT-qPCR and results were normalised to Tbp. Results are presented as mean values +/− sem, n≥3. One-tailed student’s t-test * p<0.05, ** p<0.01, *** p<0.001.
Recombinant Mouse Wnt3a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant mouse wnt3a/product/R&D Systems
Average 95 stars, based on 1 article reviews
recombinant mouse wnt3a - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

91
R&D Systems anti wnt3a
(A) N2A cells were transfected with pCl β-catenin S33Y or pCl empty vector and harvested for expression analysis 2 days later. Results are presented relative to the pCl control. (B, C) N2A cells were treated with either 50 ng/μl <t>Wnt3a</t> (B) or 0.1 ng/μl BMP4 (C) and harvested for RT-qPCR analysis 3 days later. 0.02% BSA in PBS was used as a negative control. (D) Genome browser graphic showing the ChIP amplified candidate CREs as well as the location of the TCF7L2 motifs and sgRNAs used in the CRISPRi experiment (GRCm38/mm10). (E) ChIP assays were performed in N2A cells using either an antibody against TCF7L2 or an isotype specific control. TCF7L2 occupancy at the indicated CREs was analysed by qPCR. Fold enrichment was calculated as 2 −ΔΔCt (IP/IgG) and is presented as mean value +/− sem. n≥3. One-tailed student’s t-test * p<0.05. (F) TCF7L2 levels were knocked-down in N2A cells by transfection of an endoribonuclease-prepared pool of TCF7L2 esiRNAs. An esiRNA pool targeting the luciferase gene was used as a negative control. Cells were harvested for expression analysis 3 days after transfection. (G) N2A cells were transfected with a plasmid co-expressing dCas9-KRAB and a sgRNA targeting the TCF7L2 motif within the indicated candidate CREs. A non-targeting sgRNA was used as a control. For all RT-qPCR reactions: Tcf7l2, Paupar and Pax6 expression levels were measured using RT-qPCR and results were normalised to Tbp. Results are presented as mean values +/− sem, n≥3. One-tailed student’s t-test * p<0.05, ** p<0.01, *** p<0.001.
Anti Wnt3a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti wnt3a/product/R&D Systems
Average 91 stars, based on 1 article reviews
anti wnt3a - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier

97
ATCC l wnt 3a atcc crl 2647 mouse
(A) N2A cells were transfected with pCl β-catenin S33Y or pCl empty vector and harvested for expression analysis 2 days later. Results are presented relative to the pCl control. (B, C) N2A cells were treated with either 50 ng/μl <t>Wnt3a</t> (B) or 0.1 ng/μl BMP4 (C) and harvested for RT-qPCR analysis 3 days later. 0.02% BSA in PBS was used as a negative control. (D) Genome browser graphic showing the ChIP amplified candidate CREs as well as the location of the TCF7L2 motifs and sgRNAs used in the CRISPRi experiment (GRCm38/mm10). (E) ChIP assays were performed in N2A cells using either an antibody against TCF7L2 or an isotype specific control. TCF7L2 occupancy at the indicated CREs was analysed by qPCR. Fold enrichment was calculated as 2 −ΔΔCt (IP/IgG) and is presented as mean value +/− sem. n≥3. One-tailed student’s t-test * p<0.05. (F) TCF7L2 levels were knocked-down in N2A cells by transfection of an endoribonuclease-prepared pool of TCF7L2 esiRNAs. An esiRNA pool targeting the luciferase gene was used as a negative control. Cells were harvested for expression analysis 3 days after transfection. (G) N2A cells were transfected with a plasmid co-expressing dCas9-KRAB and a sgRNA targeting the TCF7L2 motif within the indicated candidate CREs. A non-targeting sgRNA was used as a control. For all RT-qPCR reactions: Tcf7l2, Paupar and Pax6 expression levels were measured using RT-qPCR and results were normalised to Tbp. Results are presented as mean values +/− sem, n≥3. One-tailed student’s t-test * p<0.05, ** p<0.01, *** p<0.001.
L Wnt 3a Atcc Crl 2647 Mouse, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/l wnt 3a atcc crl 2647 mouse/product/ATCC
Average 97 stars, based on 1 article reviews
l wnt 3a atcc crl 2647 mouse - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

Image Search Results


(A) N2A cells were transfected with pCl β-catenin S33Y or pCl empty vector and harvested for expression analysis 2 days later. Results are presented relative to the pCl control. (B, C) N2A cells were treated with either 50 ng/μl Wnt3a (B) or 0.1 ng/μl BMP4 (C) and harvested for RT-qPCR analysis 3 days later. 0.02% BSA in PBS was used as a negative control. (D) Genome browser graphic showing the ChIP amplified candidate CREs as well as the location of the TCF7L2 motifs and sgRNAs used in the CRISPRi experiment (GRCm38/mm10). (E) ChIP assays were performed in N2A cells using either an antibody against TCF7L2 or an isotype specific control. TCF7L2 occupancy at the indicated CREs was analysed by qPCR. Fold enrichment was calculated as 2 −ΔΔCt (IP/IgG) and is presented as mean value +/− sem. n≥3. One-tailed student’s t-test * p<0.05. (F) TCF7L2 levels were knocked-down in N2A cells by transfection of an endoribonuclease-prepared pool of TCF7L2 esiRNAs. An esiRNA pool targeting the luciferase gene was used as a negative control. Cells were harvested for expression analysis 3 days after transfection. (G) N2A cells were transfected with a plasmid co-expressing dCas9-KRAB and a sgRNA targeting the TCF7L2 motif within the indicated candidate CREs. A non-targeting sgRNA was used as a control. For all RT-qPCR reactions: Tcf7l2, Paupar and Pax6 expression levels were measured using RT-qPCR and results were normalised to Tbp. Results are presented as mean values +/− sem, n≥3. One-tailed student’s t-test * p<0.05, ** p<0.01, *** p<0.001.

Journal: bioRxiv

Article Title: Chromatin interaction maps identify Wnt responsive cis -regulatory elements coordinating Paupar-Pax6 expression in neuronal cells

doi: 10.1101/2021.05.18.442939

Figure Lengend Snippet: (A) N2A cells were transfected with pCl β-catenin S33Y or pCl empty vector and harvested for expression analysis 2 days later. Results are presented relative to the pCl control. (B, C) N2A cells were treated with either 50 ng/μl Wnt3a (B) or 0.1 ng/μl BMP4 (C) and harvested for RT-qPCR analysis 3 days later. 0.02% BSA in PBS was used as a negative control. (D) Genome browser graphic showing the ChIP amplified candidate CREs as well as the location of the TCF7L2 motifs and sgRNAs used in the CRISPRi experiment (GRCm38/mm10). (E) ChIP assays were performed in N2A cells using either an antibody against TCF7L2 or an isotype specific control. TCF7L2 occupancy at the indicated CREs was analysed by qPCR. Fold enrichment was calculated as 2 −ΔΔCt (IP/IgG) and is presented as mean value +/− sem. n≥3. One-tailed student’s t-test * p<0.05. (F) TCF7L2 levels were knocked-down in N2A cells by transfection of an endoribonuclease-prepared pool of TCF7L2 esiRNAs. An esiRNA pool targeting the luciferase gene was used as a negative control. Cells were harvested for expression analysis 3 days after transfection. (G) N2A cells were transfected with a plasmid co-expressing dCas9-KRAB and a sgRNA targeting the TCF7L2 motif within the indicated candidate CREs. A non-targeting sgRNA was used as a control. For all RT-qPCR reactions: Tcf7l2, Paupar and Pax6 expression levels were measured using RT-qPCR and results were normalised to Tbp. Results are presented as mean values +/− sem, n≥3. One-tailed student’s t-test * p<0.05, ** p<0.01, *** p<0.001.

Article Snippet: For Wnt and Bmp treatment, approximately 3 x 10 5 N2A cells were seeded per well in a 6-well plate in either growth medium containing 50 ng/ μl Wnt3a (R&D Biosystems, 5036-wn) or in low serum medium (DMEM supplemented with 5% FBS) containing 0.1 ng/ μl BMP4 (Thermo Fisher, PHC9534) as described in (Szemes, Melegh et al. 2020).

Techniques: Transfection, Plasmid Preparation, Expressing, Quantitative RT-PCR, Negative Control, Amplification, One-tailed Test, esiRNA, Luciferase